2-IMIDAZOL-1-YL-1-PHENYL-ETHYLAMINE 2HCL, 95.0%, 1g

3-Oxo-2,3-diphenylpropanenitrile, 98%, 1g

3,7-Dibromodibenzo[b,d]thiophene, 95.0%, 1g

Naftifine Hydrochloride>98.0%(HPLC)1g

1-bromo-2-(methoxymethoxy)benzene, 95.0%, 1g

1-Indan-2-yl-ethanone, 95.0%, 10g

Methyl Bromodifluoroacetate>97.0%(GC)5g

N-Boc-1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid, 97.0%, 250mg

5-CHLORO-1H-INDAZOL-3-YLAMINE, 95%, 5g

3-Amino-2-methyl-3 H -quinazolin-4-one, 95.0%, 100mg

Recipiente de cristalización DURAN® sin pico, 40 ml, 50 mm, 10 Unidad(es)

2-Fluoro-5-(trifluoromethyl)phenylacetic acid, 98.0%, 100g

Monobutyl Itaconate>95.0%(GC)500g